Company news
Bioelectronics Corp. (OTC:BIEL) news
Bioelectronics Corp. news releases on 6ix. Latest, Jul 21, 2026: BioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial ActiPatch…
Press releases & updates
BioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial ActiPatch Launch and Anticipated Sales Growth
July 21, 2026
BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress
June 30, 2026
BioElectronics Advances ActiPatch Commercial Rollout With Electrome
June 17, 2026
ActiPatch Expands to Taiwan, Challenging Traditional Pain Management With Drug-Free Innovation
April 22, 2026
Stanford University Study Finds PSWT Provides Sustained Pain Relief for One of the Most Common Forms of Hand Arthritis
October 7, 2025
Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation
December 2, 2024
BioElectronics Corporation's Chairman Updates Investors
October 15, 2024
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
March 24, 2024
BioElectronics Corporation Announces the Publication of Pilot Study Results
February 22, 2024
BioElectronics Chairman Updates Investors
February 14, 2024
End of Year Message From the Chairman of the Board of BioElectronics
December 21, 2023
BioElectronics’ Chairman Discusses Recent Clinical Research Findings
July 22, 2022
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
April 6, 2022
BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico
March 30, 2022
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
February 28, 2022
BioElectronics Corporation Announces Major Lenders Forgoing Interest for a 3rd Consecutive Year; New Research Projects Underway
January 3, 2022
BioElectronics Corporation Reports Q3 Earnings
November 16, 2021
BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com
October 7, 2021
BioElectronics Corporation Discusses Q2 Financials
August 30, 2021
BioElectronics Corporation Reports Double Digit Quarterly Sales Growth, KT Health and DJO Launches Outpacing Forecasts
April 19, 2021
BioElectronics Corporation Announces Substantial Increase in 4th Quarter 2020 Revenue; Major Convertible Debt Holders Agree to Forego Interest in 2021
January 19, 2021
BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market
December 15, 2020
BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx -- Drug-Free Pain Therapy Devices
November 12, 2020
BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage
November 6, 2020
BioElectronics Chairman Outlines New Direction for Company
August 10, 2020
Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation
June 15, 2020
BioElectronics Announces U.S. FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain
February 3, 2020
BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly
October 7, 2019
BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
October 2, 2019
Update: BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
October 1, 2019
BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug
August 20, 2019
The Stock Day Podcast Hosts BioElectronics' to Discuss Its New Technology To Mitigate Opioid Use
July 9, 2019
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
July 1, 2019
BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Pain
June 3, 2019
BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain
May 22, 2019
BioElectronics Responds to FDA’s 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications
April 23, 2019
Northwest Specialty Hospital Now Offering Electroceutical Alternative To Opioids In Clinical Practice
March 14, 2019
BioElectronics Announces Back Pain Clinical Study with Leading Australian Pain Center
March 8, 2019
BioElectronics Files FDA Applications for Treatment of Musculoskeletal & Postoperative Pain
February 12, 2019
BioElectronics President’s Response to Stock Price Decline
December 4, 2018
BioElectronics Announces FDA Market Clearance Update
November 27, 2018
BioElectronics Announces Publication of Electroceuticals Article on Chronic Pain
October 4, 2018
BioElectronics’ President Discusses ActiPatch’s® Opioid Application
September 11, 2018
BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program
August 13, 2018
BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia's Pain Portfolio
July 23, 2018
BioElectronics Files FDA Application for Treatment of Musculoskeletal Pain
July 12, 2018
BioElectronics Corporation’s President Andy Whelan Joins Everett Jolly on “Stock Day” to Discuss Progress
June 13, 2018
B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program
May 31, 2018
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
May 29, 2018
BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application
May 11, 2018